Stockreport

Daiichi Sankyo Highlights Progress in Creating New Standards of Care for Patients Across Multiple Cancers at ASCO [Yahoo! Finance]

DAIICHI SANKYO S/ADR  (DSNKY) 
PDF Updated survival results from DESTINY-Breast03 trial of ENHERTU in patients with previously treated HER2 positive metastatic breast cancer also to be presented Invest [Read more]